Below is a list of the most recent data per US State. The data is provided by Medriva Charts and is collected from US State government websites and reports.
State | Cases in total | Deaths in total | New Cases change, last 24 hrs | New Deaths change, last 24 hrs | Cases trend week-over-week % | Deaths trend week-over-week % | Hospitalized currently in hospital | Hosp. change change, last 24 hrs | Intensive Care currently in ICU | Cases per capita average, last 7 days | Deaths per capita average, last 7 days | Hosp. per capita currently, per 1 mln | Test data description 1 data definition by source | Positivity rate (%) average, last 7 days |
California | 10,970,412 | 93,704 | 40,178 | 187 | -11.3 | +1.3 | 3,947 | -112 | 471 | 295.94 | 1.18 | 100.3 | Diagnostic test results | 9.8 |
Texas | 7,636,824 | 88,304 | 8,998 | 50 | -19.5 | -2.3 | 3,594 | -11 | 515 | 277.55 | 1.04 | 122.4 | Molecular tests (PCR + NAAT + LAMP) + antigen tests | 16.6 |
Florida | 6,998,369 | 79,761 | 9,381 | 78 | -16.2 | -9.4 | 3,817 | -11 | 442 | 298.55 | 3.03 | 175.6 | PCR tests only (since July 2021) | 19.4 |
New York | 6,203,057 | 73,360 | 5,062 | 10 | -15.2 | -21.4 | 2,427 | -28 | 236 | 296.2 | 1.08 | 125.5 | Test Results Reported | 8 |
Illinois | 3,645,961 | 39,180 | 4,880 | 20 | -5.2 | -49.3 | 1,434 | -3 | 152 | 284.67 | 0.82 | 113.9 | Molecular + Antigen tests performed | - |
Pennsylvania | 3,147,474 | 46,494 | - | - | +4.3 | +6.2 | 1,782 | -24 | 159 | 240.35 | 1.34 | 139.4 | PCR tests only | 19.7 |
North Carolina | 3,077,629 | 25,763 | - | - | -4.4 | - | 2,088 | 58 | 265 | 365.05 | 0.47 | 197.0 | Molecular (PCR) + Antigen tests reported | - |
Ohio | 3,026,110 | 39,206 | - | - | -7.5 | +11.8 | 1,532 | -43 | 186 | 294.03 | 1.14 | 131.0 | Confirmatory lab tests (PCR and molecular testing) | - |
Georgia | 2,829,283 | 39,472 | - | - | +3.3 | +4.8 | 1,854 | 128 | 204 | 343.69 | 2.04 | 173.1 | PCR/Molecular tests + Antigen tests | 12.7 |
Michigan | 2,731,787 | 37,774 | - | - | +43.6 | -25 | 1,146 | -14 | 111 | 332.03 | 1.47 | 115.0 | Diagnostic tests (incl. NAAT and PCR) | 26.6 |
New Jersey | 2,651,571 | 34,447 | 2,695 | 7 | -15.4 | -27 | 1,058 | -25 | 107 | 278.08 | 0.82 | 119.1 | PCR tests reported | n/a |
Tennessee | 2,254,029 | 27,315 | 3,217 | 31 | +6.7 | -18.4 | 911 | -23 | 103 | 394.85 | 2.12 | 132.3 | PCR tests only | n/a |
Arizona | 2,237,208 | 30,982 | - | - | -9.3 | +38.1 | 634 | -22 | 76 | 235.7 | 1.56 | 85.4 | Diagnostic tests (incl. PCR and antigen testing) | 17.2 |
Virginia | 2,011,057 | 21,249 | 2,721 | 27 | -8.9 | +14.6 | 846 | -22 | 127 | 285.73 | 1.73 | 98.5 | Received test results (PCR tests + Antigen tests) | 29 |
Massachusetts | 1,996,454 | 21,342 | - | - | -8.2 | -6.9 | 592 | 15 | 56 | 187.93 | 1.17 | 85.9 | Molecular tests + Antigen tests | 7 |
Indiana | 1,873,396 | 24,339 | 5,887 | 27 | -8.8 | -0.9 | 804 | 19 | 111 | 300.31 | 1.63 | 119.0 | PCR + Antigen tests administered | 21.9 |
Wisconsin | 1,814,420 | 15,008 | 1,845 | 3 | -8 | - | 521 | -73 | 53 | 276.34 | 0.69 | 89.3 | Diagnostic confirmatory test results (Molecular, PCR or NAAT) | 14.6 |
Washington | 1,767,263 | 13,886 | - | - | -16.4 | +43.2 | 654 | -41 | 56 | 194.27 | 2.07 | 85.0 | Molecular + Antigen Tests (excluding repeat tests) | - |
South Carolina | 1,650,748 | 18,227 | - | - | -57.3 | - | 586 | -8 | 68 | 373.44 | 0.33 | 112.3 | Viral (molecular) tests + Antigen tests + Antibody tests | - |
Minnesota | 1,621,194 | 13,393 | - | - | -2.9 | - | 567 | -30 | 47 | 251.21 | 0.78 | 100.2 | completed PCR tests + completed antigen tests | - |
Colorado | 1,620,407 | 13,833 | 2,382 | 20 | -7.7 | +21.7 | 230 | -14 | 40 | 171.3 | 1.45 | 39.6 | Test encounters (PCR tests) | 7.7 |
Missouri | 1,589,343 | 21,105 | - | - | -12.4 | -6.3 | 959 | 21 | 121 | 251.61 | 1.69 | 155.9 | PCR tests + Antigen tests | - |
Kentucky | 1,513,779 | 16,576 | - | - | -6.6 | -18.3 | 759 | -12 | 91 | 525.37 | 1.99 | 169.5 | PCR tests + Antigen tests | - |
Alabama | 1,463,933 | 20,041 | - | - | +5.7 | -71.6 | 777 | 3 | 111 | 409.85 | 0.43 | 157.9 | NAAT tests performed | 11.4 |
Louisiana | 1,410,817 | 17,777 | 2,008 | 12 | -2.3 | +18.1 | 485 | -33 | 92 | 324.52 | 2.39 | 104.4 | Molecular tests + Antigen tests | 17.6 |
Maryland | 1,210,317 | 15,107 | 1,526 | 6 | -17.9 | - | 553 | -34 | 57 | 211.76 | 1.14 | 91.3 | Electronically reported PCR tests (includes repeat tests) | 10.1 |
Oklahoma | 1,153,471 | 16,519 | - | - | -20.1 | - | 438 | -4 | 82 | 330.82 | 5.28 | 110.0 | PCR tests only (since June 2021) | - |
Utah | 1,023,669 | 4,953 | - | - | - | - | 192 | -10 | 22 | 361.63 | 1.11 | 59.1 | PCR and antigen test results | - |
Arkansas | 921,796 | 11,851 | 966 | 10 | -3.4 | -33.3 | 320 | -7 | 63 | 285.75 | 1.85 | 105.6 | PCR tests + Antigen tests reported | 17.4 |
Puerto Rico | 901,215 | 4,899 | 2,365 | 10 | -22.6 | +20.9 | 380 | -6 | 55 | 670.84 | 2.54 | 119.2 | Pruebas Molecular + Pruebas Antigenos | 16 |
Mississippi | 900,888 | 12,758 | 1,534 | 7 | -2.6 | - | 400 | 23 | 56 | 413.92 | 1.82 | 134.8 | PCR tests + Antigen tests | 17.2 |
Oregon | 870,690 | 8,342 | 908 | 8 | -6.3 | +33.8 | 423 | 1 | 50 | 193.8 | 2.52 | 99.7 | | 11 |
Connecticut | 868,194 | 11,180 | 1,210 | - | -17.8 | - | 427 | 33 | 47 | 171.94 | 0.59 | 120.0 | Molecular and antigen tests reported | 8 |
Kansas | 853,538 | 8,997 | - | - | -18.2 | - | 254 | 2 | 33 | 264.69 | 0.65 | 87.2 | PCR tests + Antigen tests | - |
Nevada | 837,104 | 11,353 | - | - | -25.2 | - | 209 | -15 | 34 | 119.09 | 2.55 | 66.6 | Testing encounters (molecular tests + antigen tests) | - |
Iowa | 833,187 | 9,882 | - | - | -16 | - | 243 | 12 | 32 | 214.16 | 1.45 | 76.8 | PCR tests + Antigen tests (n/a since February 9th, 2022) | - |
US Military | 702,703 | 689 | - | - | +14.8 | - | - | - | - | - | - | - | | - |
New Mexico | 605,490 | 8,347 | 678 | 5 | -15.7 | - | 145 | -15 | 25 | 275.93 | 2.37 | 68.9 | | 9.7 |
West Virginia | 572,854 | 7,234 | 861 | 4 | -11.8 | - | 417 | -26 | 51 | 434.4 | 2.46 | 233.6 | Confirmatory laboratory test results | 13.5 |
Nebraska | 525,171 | 4,445 | 832 | 13 | -7.8 | - | 207 | -12 | 20 | 197.57 | 3.77 | 106.8 | PCR tests only | n/a |
Idaho | 485,488 | 5,081 | - | - | -15.7 | - | 131 | -8 | 10 | 174.6 | 1.7 | 71.7 | PCR tests + Antigen tests | - |
Rhode Island | 412,477 | 3,632 | - | - | -100 | - | 92 | 8 | 5 | - | - | 87.0 | Test encounters | - |
New Hampshire | 342,243 | 2,646 | 206 | - | -0.4 | - | 124 | - | 8 | 142.53 | 0.66 | 90.8 | PCR and antigen tests | - |
Hawaii | 335,518 | 1,619 | - | - | -15.5 | - | 141 | -3 | 9 | 273.7 | 1.35 | 100.2 | Number of individuals tested. Individuals can contribute to multiple negative tests but only one positive test | 13.2 |
Montana | 302,455 | 3,490 | 1,848 | 9 | -0.7 | - | 89 | -3 | 10 | 244.22 | 1.2 | 82.3 | | - |
Delaware | 299,822 | 3,036 | - | - | -5.3 | - | 242 | 8 | 22 | 281.26 | 1.11 | 245.2 | | 16.1 |
Maine | 280,205 | 2,499 | 274 | 2 | +1.9 | - | 171 | 11 | 22 | 157.7 | 0.67 | 126.7 | Reported test results, molecular + antigen | 8.1 |
Alaska | 277,007 | 1,296 | - | - | -21.6 | - | 87 | 4 | 14 | 286.32 | - | 119.0 | PCR and antigen tests | - |
North Dakota | 262,554 | 2,329 | 498 | - | -15 | - | 108 | 2 | 17 | 281.83 | 0.52 | 141.2 | PCR and antigen tests | - |
South Dakota | 254,670 | 2,979 | - | - | +4.8 | - | 91 | 5 | 10 | 230.01 | 1.01 | 101.9 | PCR and antigen tests completed | 17.3 |
Wyoming | 173,487 | 1,871 | - | - | -11.9 | - | 40 | - | 3 | 248.97 | 1.55 | 68.7 | completed PCR/molecular tests | - |
District of Columbia | 165,055 | 1,376 | 240 | 2 | -27.8 | - | 200 | -6 | 18 | 136.61 | 0.42 | 280.5 | Number of Tests | - |
Vermont | 139,226 | 702 | - | - | -29.5 | - | 28 | 5 | 4 | 102.57 | 0.64 | 44.9 | PCR tested specimens | 6.2 |
Guam | 57,206 | 389 | 102 | - | -17 | - | 18 | -7 | 1 | 494.05 | 4.17 | 107.1 | Diagnostic tests (Molecular + Antigenic) | 9.4 |
US Virgin Islands | 22,300 | 122 | - | - | +17.1 | - | 9 | 2 | - | 258.49 | - | 84.9 | PCR tests and Antigen tests | 6.1 |
Northern Mariana Islands | 12,948 | 39 | - | - | -38.7 | - | - | - | - | 229.41 | - | - | | - |
American Samoa | 8,042 | 33 | - | - | -51.5 | - | - | - | - | 263.27 | - | - | | - |